TrialSpark

Series-B+
trialspark.com Biotech & Healthcare
Total Funding $156M
Latest Round $156M Series-B+
Last Announced Oct 1, 2021
Investors Undisclosed
Decision Makers 5 Verified

About TrialSpark

TrialSpark acquires clinical-stage drugs and develops them using its proprietary tech-driven drug development platform. It aims to bring new treatments to patients faster and more efficiently. TrialSpark partners with pharma, universities, and biotech companies.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website trialspark.com
Domain Registered Date Oct 22, 2014

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $156,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    Website domain registered

    trialspark.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for TrialSpark.

Funding History

1 Round
Series-B+ · Oct 1, 2021

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts